RYGB outperforms drugs, gastrectomy in lowering A1C

02/26/2013 | MedPage Today (free registration)

Roux-en-Y gastric-bypass surgery fared better than sleeve gastrectomy and optimal medical therapy in reducing A1C levels and boosting insulin sensitivity and beta-cell function in patients with diabetes, according to a study in Diabetes Care. "Gastric bypass essentially was like CPR to a failing pancreas. It was able to restore its function, and this led to durable blood sugar control for these patients," said researcher Dr. Sangeeta R. Kashyap.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT